|
|
|
|
Kyverna Therapeutics Inc (NASDAQ: KYTX) |
|
|
|
|
|
Kyverna Therapeutics Inc 's ROE per quarter
Return on Equity, Quarterly Results, Trends, Rankings, Statistics
What is ROE for Kyverna Therapeutics Inc in the first quarter 2025?
Kyverna Therapeutics Inc recorded a cumulative net loss of $-145 million during 12 months ending in the first quarter 2025, resulting in a negative return on equity (ROE) of -51.62%.
Within the Biotechnology & Pharmaceuticals industry 51 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2024 from 2894 to 2944.
What is ROE?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| Return On Equity |
(Mar 31 2025)
I. Quarter |
(Dec 31 2024)
IV. Quarter |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
| Y / Y Equity Change |
-37.95 % |
- |
- |
- |
- |
| Y / Y Net Income Change |
- |
- |
- |
- |
- |
| Net Income (TTM) in Millions |
-145 |
-127 |
-90 |
-55 |
-27 |
| Return On Equity (TTM) |
-51.62 % |
-40.35 % |
-36.1 % |
-31.96 % |
-29.58 % |
| KYTX's Total
Ranking |
# 2944 |
# 2894 |
# 0 |
# 0 |
# 0 |
| Equity (TTM) in Millions |
224 |
267 |
303 |
334 |
361 |
| Seq. Equity Change |
-15.97 % |
-11.93 % |
-9.23 % |
-7.61 % |
- |
| Seq. Net Income Change |
- |
- |
- |
- |
- |
| Return
On Equity Company Ranking |
| Within: |
No. |
| Industry |
# 52 |
| Sector |
# 394 |
| Overall |
# 2944 |
| Return On Equity Statistics |
| High |
Average |
Low |
-40.35 % |
-45.98 % |
-51.62 % |
| (Dec 31 2024) |
|
(Mar 31 2025) |
| KYTX Annual Return On Equity |
(Dec 31 2024)
2024 |
|
|
|
|
| Total Equity in Millions |
267 |
0 |
0 |
0 |
0 |
| Y / Y Equity Change |
- |
- |
- |
- |
- |
| Net Income in Millions |
-127 |
0 |
0 |
0 |
0 |
| Y / Y Net Income Change |
- |
- |
- |
- |
- |
| Return On Equity |
-47.82 % |
- |
- |
- |
- |
| Companies with similar Return On Equity at Mar 31 2025, within Healthcare Sector | ROE |
|
Date modified: 2025-05-15T04:35:49+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
